Wednesday, January 17, 2018 11:23:28 PM
Time Price Volume Market
15:54:50 0.22 2400 OTO
13:39:58 0.215148 1500 OTO
13:39:28 0.215148 2200 OTO
13:38:58 0.215148 2500 OTO
12:17:06 0.2101 490 OTO
11:51:16 0.22 1000 OTO
11:51:15 0.2199 10000 OTO
11:51:15 0.2198 10000 OTO
11:48:12 0.219801 80 OTO
10:11:22 0.2299 10000 OTO
10:11:11 0.22 21 OTO
10:11:11 0.21994 1250 OTO
10:10:41 0.22 1250 OTO
10:10:41 0.21994 1250 OTO
10:10:34 0.2299 2200 OTO
10:10:34 0.225 2500 OTO
10:10:14 0.22 2500 OTO
09:48:40 0.22 300 OTO
09:47:17 0.215 2500 OTO
09:47:04 0.215 2500 OTO
09:46:54 0.213 625 OTO
09:46:51 0.213 5000 OTO
09:46:42 0.204 2500 OTO
09:46:39 0.2036 1250 OTO
09:46:09 0.20312 1250 OTO
09:30:09 0.203108 200 OTO
Recent DSNY News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/27/2024 03:14:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 08:18:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 02:16:42 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/28/2023 11:01:54 AM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/13/2023 12:08:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/13/2023 12:01:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:57:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:56:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:49:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:44:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 11:28:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/17/2023 10:04:12 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM